Phase 1 study of the angiopoietin 1/2 neutralizing peptibody, trebananib, in acute myeloid leukemia.
Eunice S. Wang
No relevant relationships to disclose
Gerald J. Fetterly
No relevant relationships to disclose
Laura Pitzonka
No relevant relationships to disclose
William E. Brady
No relevant relationships to disclose
Wei Tan
No relevant relationships to disclose
Jessica Greene
No relevant relationships to disclose
Deborah Munster
No relevant relationships to disclose
Carlos Vigil
No relevant relationships to disclose
Jason Harold Mendler
No relevant relationships to disclose
Michael W Becker
No relevant relationships to disclose
Kristen Marie Carr-O'Dwyer
No relevant relationships to disclose
Meir Wetzler
No relevant relationships to disclose
Jane Liesveld
No relevant relationships to disclose